Free Trial
OTCMKTS:AMBBY

Ambu A/S (AMBBY) Stock Price, News & Analysis

Ambu A/S logo
$18.91 -0.22 (-1.15%)
As of 03:46 PM Eastern

About Ambu A/S Stock (OTCMKTS:AMBBY)

Key Stats

Today's Range
$18.91
$18.91
50-Day Range
$13.02
$19.14
52-Week Range
$13.02
$22.65
Volume
438 shs
Average Volume
548 shs
Market Capitalization
$4.44 billion
P/E Ratio
157.62
Dividend Yield
0.16%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

Receive AMBBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ambu A/S and its competitors with MarketBeat's FREE daily newsletter.

AMBBY Stock News Headlines

Ambu A/S (OTCMKTS:AMBBY) Shares Down 0% - Should You Sell?
Ambu A/S goes ex dividend tomorrow
Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis
Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …
Ambu A/S (AMBBY)
Ambu A/S Reports Strong Growth and Strategic Advancements
Ambu A/S (AMBFF) Q4 2024 Earnings Call Transcript
Ambu AS Class B AMBU B
See More Headlines

AMBBY Stock Analysis - Frequently Asked Questions

Ambu A/S's stock was trading at $13.02 at the beginning of 2025. Since then, AMBBY shares have increased by 45.3% and is now trading at $18.9148.
View the best growth stocks for 2025 here
.

Ambu A/S (OTCMKTS:AMBBY) announced its quarterly earnings results on Tuesday, November, 5th. The company reported ($0.08) earnings per share for the quarter. The firm had revenue of $204.32 million for the quarter. Ambu A/S had a net margin of 4.30% and a trailing twelve-month return on equity of 4.11%.

Shares of AMBBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Ex-Dividend for 12/23 Dividend
12/06/2024
Dividend Payable
12/23/2024
Today
1/21/2025
Next Earnings (Estimated)
1/30/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
OTCMKTS:AMBBY
Previous Symbol
OTCMKTS:AMBBY
CIK
N/A
Fax
N/A
Employees
5,196
Year Founded
N/A

Profitability

Net Income
$34.17 million
Pretax Margin
5.56%

Debt

Sales & Book Value

Annual Sales
$783.76 million
Cash Flow
$0.58 per share
Book Value
$3.46 per share

Miscellaneous

Free Float
N/A
Market Cap
$4.50 billion
Optionable
Not Optionable
Beta
N/A
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (OTCMKTS:AMBBY) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners